首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Inhibitory effects of a traditional Chinese herbal formula TBL-II on type II collagen-induced arthritis in mice.
【24h】

Inhibitory effects of a traditional Chinese herbal formula TBL-II on type II collagen-induced arthritis in mice.

机译:传统中草药配方TBL-II对II型胶原诱导的小鼠关节炎的抑制作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIM OF THE STUDY: TBL-II is the water extract of an anti-arthritic Chinese herbal formula Tongbiling (TBL), which has been used to treat rheumatoid arthritis (RA) for many years. We herein aimed to confirm its anti-arthritic effect and explore the potential mechanism of action on collagen-induced arthritis (CIA) in mice. MATERIALS AND METHODS: Four weeks after the first collagen immunization, mice were treated with TBL-II orally at a lower dose of 100mg/kg/d and higher dose of 300 mg/kg/d for 2 or 8 weeks. The severity of arthritis was evaluated by symptoms, radiological scores and histological assessment. Levels of IL-1beta, IL-6, TNFalpha and IgG2a type anti-collagen II (CII) antibody in serum were measured by ELISA. Competitive RT-PCR and immunohistochemical analysis were used to investigate MMP-2, -3, -9 mRNA and protein expression. RESULTS: Our results revealed treatment with higher dose of TBL-II for 2 weeks attenuated significantly acute inflammation, and decreased the amounts of IL-1beta and TNFalpha in serum; treatment for 8 weeks could obviously suppress chronic inflammation, ameliorate cartilage and bone destruction, and reduce the levels of matrix metalloproteinase (MMP)-2, -3, -9 mRNA and protein expression in joints. The levels of IgG2a type anti-CII antibody in serum were significantly reduced by treatment with higher dose of TBL-II for either 2 or 8 weeks. In contrast, treatment with lower dose of TBL-II for 8 weeks had no effect on articular destruction. CONCLUSIONS: Our results suggested that TBL-II at higher dose not only ameliorated symptoms but also modified disease of CIA. TBL-II would be a potent candidate as a novel botanical drug for further investigation.
机译:研究目的:TBL-II是一种抗关节炎的中草药配方铜比林(TBL)的水提取物,多年来一直用于治疗类风湿关节炎(RA)。我们在此旨在确认其抗关节炎作用,并探索对小鼠胶原诱导的关节炎(CIA)起作用的潜在机制。材料与方法:第一次胶原蛋白免疫后四周,以较低剂量100mg / kg / d和较高剂量300mg / kg / d口服TBL-II小鼠治疗2或8周。通过症状,放射学评分和组织学评估来评估关节炎的严重程度。通过ELISA测量血清中IL-1β,IL-6,TNFα和IgG2a型抗胶原蛋白II(CII)抗体的水平。竞争性RT-PCR和免疫组化分析用于研究MMP-2,-3,-9 mRNA和蛋白表达。结果:我们的结果显示,高剂量的TBL-II治疗2周可显着减轻急性炎症,并降低血清中IL-1beta和TNFalpha的含量;治疗8周可以明显抑制慢性炎症,改善软骨和骨破坏,并降低关节中基质金属蛋白酶(MMP)-2,-3,-9 mRNA和蛋白的表达。通过高剂量的TBL-II治疗2周或8周,血清中的IgG2a型抗CII抗体水平显着降低。相反,用较低剂量的TBL-II治疗8周对关节破坏没有影响。结论:我们的结果表明高剂量的TBL-II不仅可以缓解症状,而且可以改善CIA的疾病。 TBL-II将作为一种新型的植物药,成为有待进一步研究的有效候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号